2933.99.75.00/Lapatinib Ditosylate/China

Lapatinib Ditosylate from China

Lapatinib ditosylate is a dual tyrosine kinase inhibitor for HER2-positive breast cancer. The core quinazoline structure (aromatic heterocyclic with nitrogen) places it under HTS 2933.99.75.00 as a drug.

Duty Rate — China → United States

6.5%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Declare as 'Lapatinib ditosylate monohydrate' if hydrated form per CoA

• Include bioequivalence data if generic import competing with originator

Lapatinib Ditosylate from China — Import Duty Rate | HTS 2933.99.75.00